Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining

被引:82
作者
Letsch, A [1 ]
Scheibenbogen, C [1 ]
机构
[1] Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 3, D-12200 Berlin, Germany
关键词
D O I
10.1016/S1046-2023(03)00124-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The novel generation of sensitive T-cell assays facilitates the direct quantitation and characterization of specific T-cell responses. Functional T-cell assays such as the ELISPOT assay and the intracellular cytokine cytometry (ICC) employ the antigen-specific induction of cytokines to detect specific T-cells on a single cell level. ICC has the advantage that the simultaneous phenotypic characterization of the antigen-specific T-cells is possible. There is evidence now from clinical cancer vaccination trials, that there is a relationship between the detection of vaccine-induced T-cells by cytokine-based assays and clinical responses. As these assays become increasingly relevant in clinical practice to suggest issues of assay validation and quality control become of major importance. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 21 条
  • [1] Flow cytometric determination of intracellular or secreted IFNγ for the quantification of antigen reactive T cells
    Asemissen, AM
    Nagorsen, D
    Keilholz, U
    Letsch, A
    Schmittel, A
    Thiel, E
    Scheibenbogen, C
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 251 (1-2) : 101 - 108
  • [2] Banchereau J, 2001, CANCER RES, V61, P6451
  • [3] Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes:: Clinical and immunologic findings
    Belli, F
    Testori, A
    Rivoltini, L
    Maio, M
    Andreola, G
    Sertoli, MR
    Gallino, G
    Piris, A
    Cattelan, A
    Lazzari, I
    Carrabba, M
    Scita, G
    Santantonio, C
    Pilla, L
    Tragni, G
    Lombardo, C
    Arienti, F
    Marchianò, A
    Queirolo, P
    Bertolini, F
    Cova, A
    Lamaj, E
    Ascani, L
    Camerini, R
    Corsi, M
    Cascinelli, N
    Lewis, JJ
    Srivastava, P
    Parmiani, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4169 - 4180
  • [4] Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responses
    Bennouna, J
    Hildesheim, A
    Chikamatsu, K
    Gooding, W
    Storkus, WJ
    Whiteside, TL
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 261 (1-2) : 145 - 156
  • [5] The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8+ T lymphocytes in IFN-γ ELISPOT assays
    Britten, CM
    Meyer, RG
    Kreer, TA
    Drexler, I
    Wölfel, T
    Herr, W
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 259 (1-2) : 95 - 110
  • [6] Detection and quantification of blood-derived CD8(+) T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens
    Herr, W
    Schneider, J
    Lohse, AW
    zumBuschenfelde, KHM
    Wolfel, T
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 191 (02) : 131 - 142
  • [7] A T cell clone's avidity is a function of its activation state
    Hesse, MD
    Karulin, AY
    Boehm, BO
    Lehmann, PV
    Tary-Lehmann, M
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1353 - 1361
  • [8] Immunologic monitoring of cancer vaccine therapy: Results of a workshop sponsored by the Society for Biological Therapy
    Keilholz, U
    Weber, J
    Finke, JH
    Gabrilovich, DI
    Kast, WM
    Disis, ML
    Kirkwood, JM
    Scheibenbogen, C
    Schlom, J
    Maino, VC
    Lyerly, HK
    Lee, PP
    Storkus, W
    Marincola, F
    Worobec, A
    Atkins, MB
    [J]. JOURNAL OF IMMUNOTHERAPY, 2002, 25 (02) : 97 - 138
  • [9] Rapid effector function in CD8(+) memory T cells
    Lalvani, A
    Brookes, R
    Hambleton, S
    Britton, WJ
    Hill, AVS
    McMichael, AJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (06) : 859 - 865
  • [10] Letsch A, 2000, INT J CANCER, V87, P659, DOI 10.1002/1097-0215(20000901)87:5<659::AID-IJC7>3.3.CO